Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Embracing our differences

10.01.2011
The first Japanese human genome sequence suggests that genetics researchers may be overlooking rare but potentially important variations

While it may have been a momentous occasion in scientific history, the assembly of the first human genome sequence in 2003 was only a first step toward understanding the extent and biological importance of human genetic variation.

In fact, this ‘reference genome’—also known as NCBI36—was not derived from a single individual, but is instead a patchwork constructed from several anonymous donors. In subsequent years, research groups have taken advantage of increasingly powerful and affordable gene sequencing technology to construct full genomes from several individuals of European, African and Asian ancestry. However, such analyses still face major obstacles, even with the benefit of contemporary technology.

“Although ‘next generation’ sequencers can now sequence a human genome within a couple of weeks, sequencing errors are problematic because they are relatively frequent,” explains Tatsuhiko Tsunoda of the RIKEN Center for Genomic Medicine in Yokohama. “Sophisticated methodologies are necessary for detecting genetic variations, including single-nucleotide, copy number and structural variations.” His concern about these issues is particularly strong given his group’s involvement in the International Cancer Genome Consortium (ICGC), an organization focused on understanding how specific genomic alterations might potentially contribute to the tumor formation and progression.

Similar, but different

In partnership with RIKEN colleague Akihiro Fujimoto, Tsunoda developed more sophisticated methods for sequence data analysis. As a test of the effectiveness of their approach, they have now assembled the first complete genome sequence from an individual of Japanese ancestry[1].

Beyond its status as a landmark in genomics research, this study has also revealed a surprising number of potentially medically relevant sequence and structural variations (Fig. 2), both large and small, which have not been identified in previously assembled human sequences. In fact, their analysis of individual NA18943 revealed a striking amount of variability relative to NCBI36. “We found a roughly 0.1% difference between our assembled DNA sequences compared to the reference genome, with approximately three million base-pairs of novel sequences, as well as 3.13 million single-nucleotide variations (SNVs),” says Tsunoda.

Novel SNVs pose a particular challenge to identify, as it is often difficult to be certain whether a putative base change represents a true difference from the reference sequence or is merely the result of an error in the sequencing process. To maximize their accuracy, the researchers carefully compared three different approaches for deciding which base actually occurs at a given genomic position, developing a method that ultimately allowed them to achieve a low rate of false-positive SNV identification.

Notably, a large percentage of the novel SNVs detected in this study represented variations to genes that either disrupt protein production (nonsense mutations) or markedly alter the encoded protein sequence (nonsynonymous SNVs). The researchers hypothesize that such variations are likely to be rare within populations because of their potential contribution to human disease and as such would be strongly selected against over the course of evolution.

Tsunoda and colleagues observed a similar pattern when they compared NA18943 to six other previously characterized individual genomes. Of the nonsense SNVs identified within this collected dataset, 63% were ‘singletons’, or variants that occurred only once across all seven genome sequences. Further, the total collection of nonsynonymous SNVs contained significantly more singletons than were found among the set of non-protein-altering, synonymous SNVs.

Their analysis also revealed numerous regions where the NA18943 genome had been subject to insertions or deletions, more than 350 of which were predicted to markedly alter or disrupt the coding sequence of a gene. Notably, a significant percentage of these were detected within genes involved in olfactory or chemical stimulus perceptions, both of which are known to vary extensively between individuals.

Cause for a closer look

The researchers used a variety of established molecular biology techniques to verify the quality of these data from NA18943. Their findings collectively confirm that the genome of any given individual is likely to exhibit large numbers of rare, but functionally meaningful, variations relative to the general population or even individuals who are closely related from an evolutionary perspective. “We will have to sequence many more individuals within our population as well as across other populations around the world in order to obtain a clearer, more complete picture of the human genome,” says Tsunoda.

These findings could also have important ramifications for the conduct of studies into the genetic roots of human disease. Many such investigations are based on so-called ‘genome-wide association studies’ (GWAS), which use known SNVs as starting points for mapping sites in the genome that contribute to the pathology of complex conditions such as diabetes, rheumatoid arthritis or various forms of cancer. However, by over-emphasizing known SNVs, which are by definition more common in the general population, such studies may ignore many rare variants that offer better insight into disease pathology or are more prevalent among select populations, such as individuals of Japanese ancestry.

Tsunoda hopes this work will help steer future population-scale genetic studies as well as the group’s ongoing tumor analysis efforts for the ICGC. “Our findings promote the potential of high-accuracy personal genome sequencing,” says Tsunoda. “We have found that the variations that are functionally relevant to diseases may include lower frequency alleles that are not so common in the population as the SNVs that people are currently using for GWAS, and we may have to sequence individuals' genomes to look at such variations.”

About the Researcher: Tatsuhiko Tsunoda

Tatsuhiko Tsunoda was born in Tokyo, Japan, in 1967. He graduated with a degree in physics from the Faculty of Science at The University of Tokyo in 1989. He spent two years as a postgraduate studying elementary particle physics, and in 1995 obtained his PhD from The University of Tokyo’s Department of Engineering. After researching computational linguistics as an assistant professor of Kyoto University until 1997, he started research on human genome sequence analysis as a research associate of Institute of Medical Science at The University of Tokyo. He subsequently worked on cancer gene expression as an assistant professor. In 2000, he joined the RIKEN Center for Genomic Medicine as head of the Laboratory for Medical Informatics. He holds PhDs in medicine and engineering, and his research focuses on statistical genetic analysis of human genome variations and gene expression analysis for medical research, including methodologies for personalized medicine.

Journal information
[1] Fujimoto, A., Nakagawa, H., Hosono, N., Nakano, K., Abe, T., Boroevich, K.A., Nagasaki, M., Yamaguchi, R., Shibuya, T., Kubo, M., Miyano, S., Nakamura, Y. & Tsunoda, T. Whole-genome sequencing and comprehensive variant analysis of a Japanese individual using massively parallel sequencing. Nature Genetics 42, 931–936 (2010).

gro-pr | Research asia research news
Further information:
http://www.riken.jp
http://www.researchsea.com

More articles from Life Sciences:

nachricht The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences

nachricht Transforming plant cells from generalists to specialists
07.12.2016 | Duke University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>